5-hydroxytryptamine receptor inhibitor is safe and effective for treatment of lumbar disc
New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trialJ Neurosurg Spine. 2005 Apr;2(4):441-6
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Forty patients with sciatica due to L4-5 or L5-S1 disc herniation were randomized to receive treatment with the 5-HT2A inhibitor or nonsteroidal anti-inflammatory drugs (NSAIDs) for 2 weeks. After 2 weeks, both groups demonstrated significant reductions in low-back and leg pain as well as leg numbness, but there was no significant difference between the two groups for any of these outcomes. Over 1...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue